Benjamin L. Ebert

Benjamin Ebert is currently the Chair of Medical Oncology at Dana-Farber Cancer Institute. Prior to that, they were a Biochemistry and Biophysics Graduate Student at Brandeis University from August 2019 to May 2022. Benjamin was also previously a Gross Technician at Massachusetts General Hospital, Dermatopathology Associates from December 2017 to August 2019. In their role as a Gross Technician, they provided histology support for six pathologists in a CAP certified laboratory. Benjamin is experienced in embedded specimen slide preparation, Mohs surgical excisions, frozen sections, and microtomy. Benjamin is also well-versed in maintaining the integrity of patient privacy through good HIPPA practices.

Benjamin Ebert has a Master of Science from Brandeis University in Biochemistry and Biophysics, a Bachelor of Science from Bridgewater State University in Cell/Cellular and Molecular Biology and Biochemistry, a Bachelor of Science from UMass Boston in Exercise Health Science, and an Associate of Science from The Culinary Institute of America in Culinary Arts. Benjamin is certified from CITI Program, A Division of BRANY in Biomedical Research and Responsible Conduct of Research, Mayo Medical Laboratories in Shipping of Category A, Infectious Substance Affecting Humans and Category B, Biological Substance, American Heart Association | American Stroke Association in Advanced Cardiac Life Support and Basic Life Saver - Instructor, and National Registry of Emergency Technicians in Emergency Medical Technician - Basic.

Some of their coworkers include George D. Demetri - SVP, Experimental Therapeutics, Jennifer Willcox - SVP, General Counsel & Chief Governance Officer, and Lee M. Nadler - SVP, Experimental Medicine. Benjamin Ebert reports to Laurie H. Glimcher, President and Chief Executive Officer.